Rivaroxaban, a direct Factor Xa inhibitor, is widely used for stroke prevention in atrial fibrillation, treatment of venous thromboembolism (VTE), and postoperative thromboprophylaxis. While effective…
Apixaban is a direct oral anticoagulant (DOAC) that selectively inhibits factor Xa, thereby preventing thrombin generation and clot formation. It is commonly prescribed for stroke…